Ok so application in by April for NMPA, looks like on track for a June ish approval as flagged. Then its about converting MOUs which the company seems pretty confident of, but have been there before with no follow through.
Things starting to progress though, so given this, the risk reward to owning at these levels looks pretty good
- Forums
- ASX - By Stock
- GMV
- Ann: Prizma Clinical Trials Completed for China Approval Process
Ann: Prizma Clinical Trials Completed for China Approval Process, page-8
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)